Literature DB >> 3177749

Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited.

A Mashberg1, L J Feldman.   

Abstract

From 1961 to 1981, we evaluated 502 asymptomatic oral and oropharyngeal lesions in a veterans population of tobacco and alcohol users. Three hundred twenty-six cancers (236 invasive and 90 in situ) in 276 patients were recorded and described. For invasive cancers and in situ lesions, 64 percent and 54 percent, respectively, were red or predominantly red. Eleven percent and 16 percent were white only or predominantly white. The invasive cancers were more often granular than the in situ cancers. The traditional clinical characteristics of ulceration, induration (palpability), elevation, bleeding, and associated cervical adenopathy were not usually present in these early lesions. We found leukoplakia to be a variable characteristic as opposed to the almost constant presence of erythroplasia. These findings strongly suggest that it would probably be useful to eliminate the term leukoplakia from the discussion of cancer in a population of tobacco and alcohol users.

Entities:  

Mesh:

Year:  1988        PMID: 3177749     DOI: 10.1016/s0002-9610(88)80290-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.

Authors:  Božana Lončar-Brzak; Marko Klobučar; Irena Veliki-Dalić; Ivan Sabol; Sandra Kraljević Pavelić; Božo Krušlin; Marinka Mravak-Stipetić
Journal:  Clin Oral Investig       Date:  2017-08-04       Impact factor: 3.573

Review 2.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

Review 3.  Oral Epithelial Dysplasia and Premalignancy.

Authors:  Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2019-03-18

Review 4.  Detection of surgical margins in oral cavity cancer: the role of dynamic optical contrast imaging.

Authors:  Peter A Pellionisz; Karam W Badran; Warren S Grundfest; Maie A St John
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2018-04       Impact factor: 2.064

Review 5.  Critical evaluation of diagnostic aids for the detection of oral cancer.

Authors:  Mark W Lingen; John R Kalmar; Theodore Karrison; Paul M Speight
Journal:  Oral Oncol       Date:  2007-09-06       Impact factor: 5.337

6.  Establishing a model workplace tobacco cessation program in India.

Authors:  Gauravi A Mishra; Surendra S Shastri; Pallavi A Uplap; Parishi V Majmudar; Pallavi S Rane; Subhadra D Gupta
Journal:  Indian J Occup Environ Med       Date:  2009-08

7.  Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture.

Authors:  Easwar Natarajan; Marcela Saeb; Christopher P Crum; Sook B Woo; Phillip H McKee; James G Rheinwald
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Use of 90° Hopkin's Telescopic Examination as an OPD Tool to Clinically Evaluate and Record Oral Cavity Lesions: Our Experience in Early Detection, Especially in Patients with Limited Mouth Opening.

Authors:  Dushyant Mandlik; Karan Gupta; Daxesh Patel; Purvi Patel; Rajendra Toprani; Kaustubh Patel
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 9.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Joseph L Y Liu; Paul Brocklehurst; Anne-Marie Glenny; Mark Lingen; Alexander R Kerr; Graham Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21

Review 10.  Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions.

Authors:  Ravi Mehrotra; Anurag Gupta; Mamta Singh; Rahela Ibrahim
Journal:  Mol Cancer       Date:  2006-03-23       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.